Christian Schopke

This inventor holds 10 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 11 EPO patents. Top assignees: Cibus Europe, B.v., Cibus US LLC. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Schopke. Retrieved from https://idiyas.com/inventor/christian-schopke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Carlsbad, CA (US) (2018 - 2023)
San Diego, CA (US) (2021 - 2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570993 - MUTATED PROTOPORPHYRINOGEN IX OXIDASE (PPX) GENES (2026-03-10),

2. 12331303 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2025-06-17),

3. 11761011 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2023-09-19),

4. 11542515 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2023-01-03),

5. 11434494 - Targeted gene modification using oligonucleotide-mediated gene repair (2022-09-06),

6. 11421240 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2022-08-23),

7. 11111500 - Mutated protoporphyrinogen IX oxidase (PPX) genes (2021-09-07),

8. 10954522 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2021-03-23),

9. 10287594 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2019-05-14),

10. 9957515 - Methods and compositions for targeted gene modification (2018-05-01),

Title: The Inventive Journey of Christian Schopke: Revolutionizing Gene Modification

Introduction: Christian Schopke, an innovative inventor based in Carlsbad, CA, has made significant contributions to the field of genetic engineering with a total of 8 patents under his belt. His groundbreaking work focuses on improving the efficiency of targeted gene modification using oligonucleotide-mediated gene repair.

Latest Patents: Schopke's latest patents revolve around methods and compositions for increasing the efficiency of targeted gene modification. These patents entail techniques for effecting precise genetic changes in DNA within cells, enhancing the targeting of modifications to specific locations in genomic sequences, and combining gene repair oligonucleotides with strategies that boost the availability of components within the target cells' repair systems.

Career Highlights: Throughout his career, Schopke has spearheaded innovative research at prominent companies such as Cibus US LLC and Cibus Europe B.V. His expertise and dedication to advancing genetic engineering have led to cutting-edge developments in the field, positioning him as a pioneer in gene modification technologies.

Collaborations: Schopke has collaborated with esteemed professionals in the industry, including coworkers Peter R. Beetham and Gregory F. W. Gocal. Together, they have worked on pioneering projects that have pushed the boundaries of genetic engineering and propelled the field forward.

Conclusion: Christian Schopke's inventive prowess and unwavering commitment to advancing gene modification technologies have solidified his standing as a trailblazer in the field. His patents and collaborations stand as a testament to his valuable contributions to the realm of genetic engineering, inspiring further innovation and progress in the scientific community.

Profile summary based on public USPTO records.